Acta Neurochir (2017) 159:1663–1669 DOI 10.1007/s00701-017-3269-y ORIGINAL ARTICLE - VASCULAR Efficacy, safety, and clinical outcome of modern mechanical thrombectomy in elderly patients with acute ischemic stroke 1 2,3,4 4,5 3,4 Seungnam Son & Dong-Hun Kang & Yang-Ha Hwang & Yong-Sun Kim & 3,4,5 Yong-Won Kim Received: 27 April 2017 /Accepted: 5 July 2017 /Published online: 20 July 2017 Springer-Verlag GmbH Austria 2017 Abstract 2b-3 reperfusion (85.5% vs. 82.4%, p = 0.633), and symptom- Background The average life expectancy is increasing world- atic intracranial hemorrhage, were not different between the wide, surpassing 80 years in some countries. Recently, me- groups. A favorable clinical outcome rate was significantly chanical thrombectomy (MT) using modern devices and tech- higher in the younger group (62.4% vs. 44.1%, p =0.047). niques has led to improved clinical outcomes following acute Younger age, a low NIHSS score, and fast onset to reperfusion ischemic stroke. However, thus far, it remains uncertain time were favorable prognostic factors in elderly patients. whether MT is effective in elderly patients aged over 80 years. Conclusion Modern MT in elderly patients with acute ische- Methods Between July 2013 and June 2016, 207 patients with mic stroke is safe and effective compared to younger
Acta Neurochirurgica – Springer Journals
Published: Jul 20, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera